Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by side| Metric | ABBV | MRNA |
|---|
| Close | 294.89 | 221.72 |
| Market Cap | $522B | $88.3B |
| 1M | +12.73% | +15.14% |
| P/E (TTM) | 81.4 | — |
| Forward P/E | 16.9 | — |
| P/E 5-Yr Percentile | 62 | — |
| P/S | 8.0 | 39.7 |
| P/B | — | 13.1 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $145M |
| Revenue YoY | +10.2% | +2.1% |
| Gross Margin | 74.7% | 35.9% |
| Latest Quarter EPS | 2.03 | -1.97 |
| Avg Post-Earnings Move | ±1.7% | ±4.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | — |
| 90-Day Net Insider Buying | −$8.2M | −$62.6M |
ABBV · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
